NLRP3 and fibrosis: Klotho, which mitigates diabetes-induced elevation of serum creatine kinase-muscle/brain (CK-MB) and LDH, cardiac fibrosis, cardiomyocyte apoptosis, and cardiac dysfunction, also inhibits NLRP3 activation and TNF-α, IL-1β, and IL-18 expression.